MGTX
Price
$8.37
Change
+$0.06 (+0.72%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
672.66M
12 days until earnings call
XOMAP
Price
$25.55
Change
-$0.20 (-0.78%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

MGTX vs XOMAP

Header iconMGTX vs XOMAP Comparison
Open Charts MGTX vs XOMAPBanner chart's image
MeiraGTx Holdings
Price$8.37
Change+$0.06 (+0.72%)
Volume$5.53K
Capitalization672.66M
XOMA
Price$25.55
Change-$0.20 (-0.78%)
VolumeN/A
CapitalizationN/A
MGTX vs XOMAP Comparison Chart in %
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. XOMAP commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Hold and XOMAP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (MGTX: $8.37 vs. XOMAP: $25.75)
Brand notoriety: MGTX and XOMAP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 82% vs. XOMAP: 39%
Market capitalization -- MGTX: $672.66M vs. XOMAP: $0
MGTX [@Biotechnology] is valued at $672.66M. XOMAP’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileXOMAP’s FA Score has 1 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • XOMAP’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMAP is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 4 TA indicator(s) are bullish while XOMAP’s TA Score has 6 bullish TA indicator(s).

  • MGTX’s TA Score: 4 bullish, 5 bearish.
  • XOMAP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XOMAP is a better buy in the short-term than MGTX.

Price Growth

MGTX (@Biotechnology) experienced а -2.90% price change this week, while XOMAP (@Biotechnology) price change was +0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MGTX is expected to report earnings on Nov 06, 2025.

XOMAP is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX YTD gains are higher at: 37.438 vs. XOMAP (5.962). XOMAP has higher annual earnings (EBITDA): 6M vs. MGTX (-141.78M). XOMAP has more cash in the bank: 93.3M vs. MGTX (66.5M). MGTX has less debt than XOMAP: MGTX (80.9M) vs XOMAP (114M). MGTX has higher revenues than XOMAP: MGTX (34.5M) vs XOMAP (13M).
MGTXXOMAPMGTX / XOMAP
Capitalization673MN/A-
EBITDA-141.78M6M-2,363%
Gain YTD37.4385.962628%
P/E RatioN/AN/A-
Revenue34.5M13M265%
Total Cash66.5M93.3M71%
Total Debt80.9M114M71%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGTXXOMAP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
10%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
20%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
26%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
21%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
26%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 11 days ago
23%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 4 days ago
19%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
4%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ATM.X1.1345310.068365
+6.41%
Atletico De Madrid Fan Token cryptocurrency
HIGH.X0.6241630.014554
+2.39%
Highstreet cryptocurrency
TKO170.052.05
+1.22%
TKO Group Holdings
JANX25.96-0.01
-0.04%
Janux Therapeutics
ABEO6.53-0.12
-1.80%
Abeona Therapeutics

XOMAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAP has been loosely correlated with AMLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMAP jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAP
1D Price
Change %
XOMAP100%
N/A
AMLX - XOMAP
51%
Loosely correlated
-1.81%
CGEN - XOMAP
31%
Poorly correlated
-0.65%
RNAC - XOMAP
29%
Poorly correlated
-0.97%
XOMAO - XOMAP
27%
Poorly correlated
-0.01%
MGTX - XOMAP
26%
Poorly correlated
+0.72%
More